您使用提示模式 关闭
为了方块之间的快速移动

组织机构: Charles River Laboratories International
LEI 549300BSQ0R4UZ5KX287

机构名称
Charles River Laboratories International, Inc.
国家名称
美国
注册登记国
美国
行业
专业服务
债券负债
1.500 百万 USD

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件

最新数据在

卖价

查询已发送
无法访问
信息提供者所提供的报价仅供参考。

简介

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

奖项

相关文件

股票

最近一次的发行

债券负债 (按货币)

代码

  • LEI
    549300BSQ0R4UZ5KX287
  • SIC
    8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
  • ICB
    4.500 Health Care
  • CIK
    0001100682
  • EIN
    06-1397316

信用和 ESG 评级

宏观经济指数

你必须 注册 才能获得访问权